• LAST PRICE
    317.3200
  • TODAY'S CHANGE (%)
    Trending Up4.4600 (1.4256%)
  • Bid / Lots
    317.2400/ 1
  • Ask / Lots
    317.4200/ 1
  • Open / Previous Close
    313.6800 / 312.8600
  • Day Range
    Low 313.3700
    High 318.4500
  • 52 Week Range
    Low 249.7001
    High 346.8500
  • Volume
    1,039,416
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Wednesday's close: 312.86
TimeVolumeAMGN
09:32 ET51299314.8748
09:34 ET16427314.75
09:36 ET4088314.8334
09:38 ET6317315.4
09:39 ET12900314.94
09:41 ET13006314.45
09:43 ET3812315.105
09:45 ET3489315.085
09:48 ET3342315.39
09:50 ET5945316.12
09:52 ET8571315.8
09:54 ET2781315.045
09:56 ET10242315.18
09:57 ET3669315.56
09:59 ET7854315.765
10:01 ET19526317.255
10:03 ET11591317.6794
10:06 ET10499316.44
10:08 ET7227316.195
10:10 ET4807316.1499
10:12 ET11581316.0725
10:14 ET7505316.3
10:15 ET7976316.23
10:17 ET5019316.2925
10:19 ET3337316.805
10:21 ET1767316.96
10:24 ET4187316.62
10:26 ET1142316.71
10:28 ET3816317
10:30 ET3060316.865
10:32 ET2283316.845
10:33 ET5997317.49
10:35 ET2884317.91
10:37 ET3152318.17
10:39 ET2584318.14
10:42 ET5266318.11
10:44 ET2190317.62
10:46 ET1827317.39
10:48 ET1648317.53
10:50 ET1700317.46
10:51 ET2095317.6286
10:53 ET4245317.77
10:55 ET8391317.61
10:57 ET3431317.47
11:00 ET2448317.54
11:02 ET2752318.24
11:04 ET3713318.08
11:06 ET1665317.93
11:08 ET11232318.19
11:09 ET2914318.23
11:11 ET1689318.11
11:13 ET2200317.515
11:15 ET650317.36
11:18 ET300317.54
11:20 ET2544317.36
11:22 ET1326317.1777
11:24 ET3078317.095
11:26 ET3266317.52
11:27 ET420317.44
11:29 ET487317.39
11:31 ET900317.25
11:33 ET700317.1168
11:36 ET4605317.275
11:38 ET400316.96
11:40 ET563316.86
11:42 ET336316.8666
11:44 ET691316.6
11:45 ET1686316.85
11:47 ET827316.86
11:51 ET713316.375
11:54 ET1520316.735
11:56 ET400316.81
11:58 ET920316.98
12:00 ET700317
12:02 ET450316.88
12:03 ET200316.89
12:05 ET7238316.8
12:07 ET1834316.81
12:09 ET1572317.37
12:12 ET1400317.27
12:14 ET900317.33
12:16 ET1000317.235
12:18 ET859317.3699
12:20 ET1330317.555
12:21 ET821317.74
12:23 ET6595317.87
12:25 ET3495317.89
12:27 ET21300317.785
12:30 ET300317.82
12:32 ET429317.83
12:34 ET2105318
12:36 ET1731318.04
12:38 ET1483318.19
12:39 ET250318.24
12:41 ET1110318.05
12:43 ET6361317.885
12:45 ET4475317.98
12:48 ET2062318.2
12:50 ET6526318.08
12:52 ET900317.9
12:54 ET200317.935
12:56 ET700318.05
12:57 ET300317.885
01:01 ET400317.79
01:03 ET1116317.85
01:06 ET4373317.82
01:08 ET1933318.16
01:10 ET1148318.18
01:12 ET800317.79
01:14 ET2300317.45
01:15 ET999317.54
01:17 ET650317.43
01:19 ET1000317.31
01:21 ET752317.35
01:24 ET4115317.605
01:26 ET1459317.5
01:28 ET1433317.12
01:30 ET700317.47
01:32 ET1772317.6
01:33 ET1835317.925912
01:35 ET1400317.54
01:37 ET1256317.83
01:39 ET900317.7
01:42 ET1261317.48
01:44 ET300317.32
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesAMGN
Amgen Inc
168.1B
54.6x
-0.22%
United StatesGILD
Gilead Sciences Inc
102.4B
101.2x
+1.53%
United StatesHLN
Haleon PLC
48.1B
33.8x
---
United StatesBMY
Bristol-Myers Squibb Co
101.3B
-15.3x
+4.90%
United StatesAZN
AstraZeneca PLC
238.9B
37.9x
+17.52%
United StatesSNY
Sanofi SA
145.3B
30.5x
+4.55%
As of 2024-09-26

Company Information

Amgen Inc. is a biotechnology company. The Company discovers, develops, manufactures and delivers various human therapeutics. It focuses on areas of high unmet medical need and leverages its expertise to strive for solutions that improve health outcomes and improve people's lives. It operates in human therapeutics segment. The Company’s marketed products portfolio includes Aranesp, ENBREL, Prolia (denosumab), Neulasta (pegfilgrastim), Otezla, XGEVA, Aranesp (darbepoetin alfa), KYPROLIS, Repatha (evolocumab), Nplate (romiplostim), Vectibix (panitumumab), MVASI (bevacizumab-awwb), Parsabiv (etelcalcetide), EPOGEN (epoetin alfa), KANJINTI (trastuzumab-anns), BLINCYTO (blinatumomab), Aimovig (erenumab-aooe), EVENITY (romosozumab-aqqg), AMGEVITATM (adalimumab), Sensipar/Mimpara (cinacalcet), NEUPOGEN (filgrastim), IMLYGIC (talimogene laherparepvec), Corlanor (ivabradine), KYPROLIS (carfilzomib), Maridebart cafraglutide, (infliximab-axxq), Evenity, LumaKras, Nplate and XGeva, others.

Contact Information

Headquarters
One Amgen Center DriveTHOUSAND OAKS, CA, United States 91320
Phone
805-447-1000
Fax
805-447-1010

Executives

Chairman of the Board, President, Chief Executive Officer
Robert Bradway
Chief Financial Officer, Executive Vice President
Peter Griffith
Executive Vice President, Chief Technology Officer
David Reese
Executive Vice President, Research and Development, and Chief Scientific Officer
James Bradner
Executive Vice President, General Counsel, Secretary
Jonathan Graham

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$168.1B
Revenue (TTM)
$30.9B
Shares Outstanding
537.3M
Dividend Yield
2.84%
Annual Dividend Rate
9.0000 USD
Ex-Dividend Date
08-16-24
Pay Date
09-06-24
Beta
0.60
EPS
$5.81
Book Value
$11.64
P/E Ratio
54.6x
Price/Sales (TTM)
5.4
Price/Cash Flow (TTM)
20.5x
Operating Margin
20.81%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.